© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
September 22, 2020
July 15, 2020
ONCOLOGY® Editor in chief Julie M. Vose, MD, MBA discusses both the positive and negative changes that have come about because of the COVID-19 pandemic.
May 13, 2020
Editor in chief Julie M. Vose, MD, MBA discusses the difficulties of treating and caring for patients with cancer during the COVID-19 pandemic.
May 14, 2019
In this article, we present a case of a patient with relapsed Hodgkin lymphoma who responded to salvage chemotherapy incorporating brentuximab vedotin, a novel agent.